Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.

Antimicrobial Agents and Chemotherapy
Aeron C HurtJ L McKimm-Breschkin

Abstract

An influenza B virus from an infant with no history of treatment or contact with neuraminidase inhibitors demonstrated a significant reduction in sensitivity to these drugs. Here, we describe the analysis of a mixed viral population that contained a novel D197E amino acid substitution that was responsible for this reduction.

References

Oct 1, 1994·Protein Science : a Publication of the Protein Society·P M Colman
Oct 21, 1998·The Journal of Infectious Diseases·L V GubarevaR G Webster
Aug 10, 2000·Antiviral Research·J L McKimm-Breschkin
Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Feb 27, 2001·The Pediatric Infectious Disease Journal·R J WhitleyP Ward
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·N A Roberts

❮ Previous
Next ❯

Citations

Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mariana BazGuy Boivin
Mar 28, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gregory A PolandInna G Ovsyannikova
Aug 5, 2009·Antimicrobial Agents and Chemotherapy·Aeron C HurtIan G Barr
Aug 17, 2011·Antimicrobial Agents and Chemotherapy·Mitsutaka KitanoKazumasa Ogasawara
Nov 22, 2011·Emerging Infectious Diseases·Katrina SleemanLarisa V Gubareva
Dec 2, 2014·BMC Research Notes·Muhammad Raihan JumatBoon-Huan Tan
Dec 5, 2006·Expert Review of Anti-infective Therapy·Aeron C HurtIan Barr
Apr 10, 2009·Expert Opinion on Drug Safety·Patricia Schirmer, Mark Holodniy
May 27, 2014·Clinics in Laboratory Medicine·Jennifer Laplante, Kirsten St George
May 10, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jang Su KimChang Kyu Lee
Dec 7, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Vanessa EscuretOlivier Ferraris
Jan 4, 2013·Influenza and Other Respiratory Viruses·Jennifer L McKimm-Breschkin
Jul 3, 2007·The American Journal of Medicine·Robert C MoelleringLawrence Corey
Nov 6, 2007·American Journal of Infection Control·Robert C MoelleringUNKNOWN American Society for Microbiology
Apr 4, 2016·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shu-Ming KuoShin-Ru Shih
Mar 27, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Seiichiro FujisakiTakato Odagiri
Sep 10, 2013·Antiviral Research·Andrew J BurnhamElena A Govorkova
Dec 17, 2014·Antiviral Research·Jennifer L McKimm-Breschkin, Susan Barrett
Mar 6, 2015·Journal of Virology·Henju MarjukiLarisa V Gubareva
Aug 21, 2007·Journal of Medical Virology·Phillip Andrew Reece
Aug 11, 2010·Journal of Medicinal Chemistry·Aaron J OakleyJennifer L McKimm-Breschkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.